Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...
NORTHAMPTON, MA / ACCESS Newswire / November 18, 2025 / SLR - A new investor-led report calls on global pharmaceutical companies to reassess the commercial potential of low- and middle-income ...
Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...
Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...
A new analysis finds medicines often are not accessible countries where they were tested before approval by the FDA, raising ...
Robbie Williams warns GLP-1 drugs may cause vision loss. What does this mean for food & beverage innovation and natural ...
· In return for their investment in U.S. manufacturing, the administration would drop a proposed 100% tariffs on branded and patented drugs imported to the U.S. · Trump’s push for most-favored-nation ...
In the past, biosimilar makers have been able to invalidate some of those patents through a sped-up process called “inter ...
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.
At the urging of the vast majority of the state attorneys general, they voted to table an amendment to strip this provision.” ...
Our ability to sustain ourselves in the future could be really compromised if this becomes the law of the land.” ...
More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build muscle, rejuvenate skin and extend life, the latest example of the nation’s fascination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback